Clinical Research Directory
Browse clinical research sites, groups, and studies.
Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) Infection
Sponsor: University of Alabama at Birmingham
Summary
This clinical imaging study will use the small molecule translocator protein (TSPO) ligand, Fluorodeoxyglucose(18F)-labeled DPA-714, to visualize and quantify neuroinflammation in individuals with post-acute sequelae of SARS-CoV-2 (PASC) . The brain uptake of DPA-714 will be contrasted with healthy subjects.
Official title: PET Imaging of Neuroinflammation in Patients With Neurological Dysfunction After SARS-CoV-2 Infection
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-11-10
Completion Date
2028-06-01
Last Updated
2025-12-11
Healthy Volunteers
Yes
Conditions
Interventions
DPA-714 PET/MRI
DPA-714 PET/MRI
Locations (1)
UAB
Birmingham, Alabama, United States